Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Veozah is the first nonhormonal medication to treat hot flashes in menopausal women; it was recently approved by the F.D.A.
Simplified Text
Veozah is the first nonhormonal medication for treating hot flashes in menopausal women, and it was recently approved by the F.D.A.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "medication": "Veozah",
    "approval_body": "F.D.A."
}
Subject Tags
Health Medication FDA Approval Women's Health
UUID
ed310213-2efd-4410-9f24-55da1add49ce
Vector Index
✗ No vector
Created
October 1, 2026 at 11:08 AM (1 week ago)
Last Updated
October 1, 2026 at 11:08 AM (1 week ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/09/well/live/dexa-scan-bone-density-menopause.html
When Do Women Really Need a Bone Scan?
Completed Analysis
12 claims 🔥
1 week ago
https://nytimes.com/2026/09/09/well/live/dexa-scan-bone-density-menopause.html

A cultural push suggests women in midlife consider DEXA scans earlier than traditionally recommended to prevent osteoporosis. While medical organizations recommend scans at 65, some experts advocate for earlier screening, especially around menopause, to preserve bone density.

DEXA Scan Bone Density Osteoporosis Menopause Women's Health Preventive Health

Similar Claims (5)

Other claims identified as semantically similar to this one.